DGX

Quest Diagnostics INC

Insider trading activity for Quest Diagnostics INC, straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$8.3M

net selling

Bought(0 · 0 insiders): $0
Sold(5 · 3 insiders): $8.3M

Past 6 months

-$11.9M

net selling

Bought(0 · 0 insiders): $0
Sold(7 · 4 insiders): $11.9M

Past 12 months

-$37.3M

net selling

Bought(0 · 0 insiders): $0
Sold(30 · 8 insiders): $37.3M

Transaction history

The 100 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 1	Davis J. E.	CEO and President	SSELL◷	10,000	$242.72	$2.4M	-7.5%	Open the original filing on SEC.gov
Aug 28	Prevoznik Michael E	SVP & General Counsel	MEXER◷◆	22,677	$112.17	$2.5M	—	Open the original filing on SEC.gov
Aug 28	Prevoznik Michael E	SVP & General Counsel	GGIFT◷	1,000	—	—	-2.7%	Open the original filing on SEC.gov
Aug 28	Prevoznik Michael E	SVP & General Counsel	SSELL◷	430	$244.51	$105.1K	-1.1%	Open the original filing on SEC.gov
Aug 28	Prevoznik Michael E	SVP & General Counsel	SSELL◷	6,237	$243.63	$1.5M	-14.1%	Open the original filing on SEC.gov
Aug 28	Prevoznik Michael E	SVP & General Counsel	SSELL◷	16,010	$242.88	$3.9M	-26.6%	Open the original filing on SEC.gov
Aug 28	Prevoznik Michael E	SVP & General Counsel	MEXER◷	22,677	$112.17	$2.5M	+60.4%	Open the original filing on SEC.gov
Jul 28	Delaney Mark E	SVP & Chief Commercial…	SSELL◷	1,600	$235.18	$376.3K	-13.4%	Open the original filing on SEC.gov
Jul 22	Samad Sam	Executive Vice President…	AGRANT	102	$206.81	$21.1K	+0.3%	Open the original filing on SEC.gov
Jul 22	Plewman Patrick	SVP for Diagnostic…	LSMALL	46	$206.81	$9.5K	+0.3%	Open the original filing on SEC.gov
Jul 22	Main Timothy L	Director	LSMALL	21	$206.81	$4.3K	+<0.1%	Open the original filing on SEC.gov
Jul 22	Lassiter Wright III	Director	LSMALL	6	$206.81	$1.2K	+<0.1%	Open the original filing on SEC.gov
Jul 22	Kuppusamy Karthik	SVP, Clinical Solutions	LSMALL	37	$206.81	$7.7K	+0.3%	Open the original filing on SEC.gov
Jul 22	Gregg Vicky B	Director	AGRANT	72	$206.81	$14.9K	+0.4%	Open the original filing on SEC.gov
Jul 22	Delaney Mark E	SVP & Chief Commercial…	LSMALL	34	$206.81	$7K	+0.3%	Open the original filing on SEC.gov
Jul 22	Carter Robert B	Director	LSMALL	11	$206.80	$2.3K	+0.3%	Open the original filing on SEC.gov
Jul 1	Wentworth Timothy C	Director	AGRANT◆	144	—	—	—	Open the original filing on SEC.gov
Jun 4	Kuppusamy Karthik	SVP, Clinical Solutions	MEXER◷◆	4,827	$121.81	$588K	—	Open the original filing on SEC.gov
Jun 4	Kuppusamy Karthik	SVP, Clinical Solutions	MEXER◷◆	3,320	$127.73	$424K	—	Open the original filing on SEC.gov
Jun 4	Kuppusamy Karthik	SVP, Clinical Solutions	SSELL◷	8,147	$200.00	$1.6M	-37.6%	Open the original filing on SEC.gov
Jun 4	Kuppusamy Karthik	SVP, Clinical Solutions	MEXER◷	4,827	$121.81	$588K	+28.7%	Open the original filing on SEC.gov
Jun 4	Kuppusamy Karthik	SVP, Clinical Solutions	MEXER◷	3,320	$127.73	$424K	+24.6%	Open the original filing on SEC.gov
Jun 1	Davis J. E.	CEO and President	SSELL◷	10,000	$194.14	$1.9M	-7.0%	Open the original filing on SEC.gov
May 20	Wentworth Timothy C	Director	AGRANT	1,142	—	—	+528.7%	Open the original filing on SEC.gov
May 20	Ring Timothy M	Director	AGRANT	1,142	—	—	+3.8%	Open the original filing on SEC.gov
May 20	Pfeiffer Gary M	Director	AGRANT	1,142	—	—	+3.8%	Open the original filing on SEC.gov
May 20	Morrison Denise M	Director	AGRANT	1,142	—	—	+10.6%	Open the original filing on SEC.gov
May 20	Main Timothy L	Director	AGRANT	1,142	—	—	+4.3%	Open the original filing on SEC.gov
May 20	Lassiter Wright III	Director	AGRANT	1,142	—	—	+12.4%	Open the original filing on SEC.gov
May 20	Gregg Vicky B	Director	AGRANT	1,142	—	—	+6.7%	Open the original filing on SEC.gov
May 20	Doi Tracey	Director	AGRANT	1,142	—	—	+17.3%	Open the original filing on SEC.gov
May 20	Diaz Luis	Director	AGRANT	1,142	—	—	+28.2%	Open the original filing on SEC.gov
May 20	Carter Robert B	Director	AGRANT	1,142	—	—	+42.1%	Open the original filing on SEC.gov
Apr 20	Samad Sam	Executive Vice President…	AGRANT	108	$194.70	$21K	+0.3%	Open the original filing on SEC.gov
Apr 20	Plewman Patrick	SVP for Diagnostic…	LSMALL	49	$194.70	$9.5K	+0.3%	Open the original filing on SEC.gov
Apr 20	Lassiter Wright III	Director	LSMALL	6	$194.70	$1.2K	+<0.1%	Open the original filing on SEC.gov
Apr 20	Kuppusamy Karthik	SVP, Clinical Solutions	LSMALL	39	$194.70	$7.6K	+0.3%	Open the original filing on SEC.gov
Apr 20	Gregg Vicky B	Director	AGRANT	68	$194.70	$13.2K	+0.4%	Open the original filing on SEC.gov
Apr 20	Delaney Mark E	SVP & Chief Commercial…	LSMALL	37	$194.70	$7.2K	+0.3%	Open the original filing on SEC.gov
Apr 20	Carter Robert B	Director	LSMALL	7	$194.70	$1.4K	+0.3%	Open the original filing on SEC.gov
Apr 1	Wentworth Timothy C	Director	AGRANT◆	198	—	—	—	Open the original filing on SEC.gov
Mar 9	Wentworth Timothy C	Director	AGRANT	215	—	—	—	Open the original filing on SEC.gov
Mar 5	Plewman Patrick	SVP for Diagnostic…	SSELL◷	2,855	$206.21	$588.7K	-15.8%	Open the original filing on SEC.gov
Mar 5	Prevoznik Michael E	SVP & General Counsel	SSELL◷	3,878	$206.21	$799.7K	-9.4%	Open the original filing on SEC.gov
Mar 5	Doherty Catherine T.	EVP, Regional Businesses	SSELL◷	5,558	$206.21	$1.1M	-7.6%	Open the original filing on SEC.gov
Mar 4	Samad Sam	Executive Vice President…	FTAX	7,720	$204.86	$1.6M	-18.8%	Open the original filing on SEC.gov
Mar 4	Samad Sam	Executive Vice President…	AGRANT	13,947	$204.86	$2.9M	+51.6%	Open the original filing on SEC.gov
Mar 4	Plewman Patrick	SVP for Diagnostic…	FTAX◷	2,827	$204.86	$579.1K	-13.5%	Open the original filing on SEC.gov
Mar 4	Plewman Patrick	SVP for Diagnostic…	AGRANT◷	5,682	$204.86	$1.2M	+37.4%	Open the original filing on SEC.gov
Mar 4	Prevoznik Michael E	SVP & General Counsel	FTAX◷	3,354	$204.86	$687.1K	-7.5%	Open the original filing on SEC.gov
Mar 4	Prevoznik Michael E	SVP & General Counsel	AGRANT◷	7,232	$204.86	$1.5M	+19.3%	Open the original filing on SEC.gov
Mar 4	Kuppusamy Karthik	SVP, Clinical Solutions	SSELL	2,628	$204.86	$538.4K	-16.4%	Open the original filing on SEC.gov
Mar 4	Kuppusamy Karthik	SVP, Clinical Solutions	AGRANT	6,200	$204.86	$1.3M	+62.8%	Open the original filing on SEC.gov
Mar 4	Doherty Catherine T.	EVP, Regional Businesses	FTAX◷	5,806	$204.86	$1.2M	-7.4%	Open the original filing on SEC.gov
Mar 4	Doherty Catherine T.	EVP, Regional Businesses	AGRANT◷	11,364	$204.86	$2.3M	+16.9%	Open the original filing on SEC.gov
Mar 4	Deppe Michael J	SVP, Corp. Controller &…	FTAX	750	$204.86	$153.6K	-2.1%	Open the original filing on SEC.gov
Mar 4	Deppe Michael J	SVP, Corp. Controller &…	AGRANT	1,473	$204.86	$301.8K	+4.3%	Open the original filing on SEC.gov
Mar 4	Davis J. E.	CEO and President	FTAX	26,414	$204.86	$5.4M	-15.6%	Open the original filing on SEC.gov
Mar 4	Davis J. E.	CEO and President	AGRANT	51,652	$204.86	$10.6M	+44.1%	Open the original filing on SEC.gov
Mar 4	Delaney Mark E	SVP & Chief Commercial…	FTAX	2,326	$204.86	$476.5K	-16.4%	Open the original filing on SEC.gov
Mar 4	Delaney Mark E	SVP & Chief Commercial…	AGRANT	5,682	$204.86	$1.2M	+66.8%	Open the original filing on SEC.gov
Mar 3	Plewman Patrick	SVP for Diagnostic…	SSELL◷	410	$207.73	$85.2K	-2.6%	Open the original filing on SEC.gov
Mar 3	Prevoznik Michael E	SVP & General Counsel	SSELL◷	526	$207.73	$109.3K	-1.4%	Open the original filing on SEC.gov
Mar 3	Doherty Catherine T.	EVP, Regional Businesses	SSELL◷	632	$207.73	$131.3K	-0.9%	Open the original filing on SEC.gov
Mar 2	Samad Sam	Executive Vice President…	FTAX	869	$204.86	$178K	-3.1%	Open the original filing on SEC.gov
Mar 2	Plewman Patrick	SVP for Diagnostic…	FTAX◷	230	$204.86	$47.1K	-1.5%	Open the original filing on SEC.gov
Mar 2	Prevoznik Michael E	SVP & General Counsel	FTAX◷	288	$204.86	$59K	-0.8%	Open the original filing on SEC.gov
Mar 2	Kuppusamy Karthik	SVP, Clinical Solutions	FTAX	205	$204.86	$42K	-2.0%	Open the original filing on SEC.gov
Mar 2	Doherty Catherine T.	EVP, Regional Businesses	FTAX◷	648	$204.86	$132.7K	-0.9%	Open the original filing on SEC.gov
Mar 2	Deppe Michael J	SVP, Corp. Controller &…	FTAX	88	$204.86	$18K	-0.3%	Open the original filing on SEC.gov
Mar 2	Davis J. E.	CEO and President	SSELL◷	10,000	$212.52	$2.1M	-7.9%	Open the original filing on SEC.gov
Mar 2	Davis J. E.	CEO and President	FTAX◷	2,968	$204.86	$608K	-2.3%	Open the original filing on SEC.gov
Mar 2	Delaney Mark E	SVP & Chief Commercial…	FTAX	188	$204.86	$38.5K	-2.2%	Open the original filing on SEC.gov
Feb 19	Plewman Patrick	SVP for Diagnostic…	SSELL◷	958	$204.83	$196.2K	-5.7%	Open the original filing on SEC.gov
Feb 19	Prevoznik Michael E	SVP & General Counsel	SSELL◷	1,111	$204.83	$227.6K	-2.8%	Open the original filing on SEC.gov
Feb 19	Doherty Catherine T.	EVP, Regional Businesses	SSELL◷	1,433	$204.83	$293.5K	-2.1%	Open the original filing on SEC.gov
Feb 18	Samad Sam	Executive Vice President…	AGRANT◆	18,303	—	—	—	Open the original filing on SEC.gov
Feb 18	Samad Sam	Executive Vice President…	FTAX	1,010	$206.99	$209.1K	-3.5%	Open the original filing on SEC.gov
Feb 18	Samad Sam	Executive Vice President…	FTAX	855	$210.01	$179.6K	-2.9%	Open the original filing on SEC.gov
Feb 18	Samad Sam	Executive Vice President…	AGRANT	3,965	—	—	+15.4%	Open the original filing on SEC.gov
Feb 18	Plewman Patrick	SVP for Diagnostic…	AGRANT◷◆	9,009	—	—	—	Open the original filing on SEC.gov
Feb 18	Plewman Patrick	SVP for Diagnostic…	FTAX◷	293	$206.99	$60.6K	-1.7%	Open the original filing on SEC.gov
Feb 18	Plewman Patrick	SVP for Diagnostic…	FTAX◷	244	$210.01	$51.2K	-1.4%	Open the original filing on SEC.gov
Feb 18	Plewman Patrick	SVP for Diagnostic…	AGRANT◷	1,952	—	—	+12.7%	Open the original filing on SEC.gov
Feb 18	Prevoznik Michael E	SVP & General Counsel	AGRANT◷◆	9,289	—	—	—	Open the original filing on SEC.gov
Feb 18	Prevoznik Michael E	SVP & General Counsel	FTAX◷	347	$206.99	$71.8K	-0.9%	Open the original filing on SEC.gov
Feb 18	Prevoznik Michael E	SVP & General Counsel	FTAX◷	301	$210.01	$63.2K	-0.8%	Open the original filing on SEC.gov
Feb 18	Prevoznik Michael E	SVP & General Counsel	AGRANT◷	2,013	—	—	+5.3%	Open the original filing on SEC.gov
Feb 18	Kuppusamy Karthik	SVP, Clinical Solutions	AGRANT◆	9,853	—	—	—	Open the original filing on SEC.gov
Feb 18	Kuppusamy Karthik	SVP, Clinical Solutions	AGRANT	2,135	—	—	+27.0%	Open the original filing on SEC.gov
Feb 18	Kuppusamy Karthik	SVP, Clinical Solutions	FTAX	259	$206.99	$53.6K	-3.2%	Open the original filing on SEC.gov
Feb 18	Kuppusamy Karthik	SVP, Clinical Solutions	FTAX	252	$210.01	$52.9K	-3.0%	Open the original filing on SEC.gov
Feb 18	Doherty Catherine T.	EVP, Regional Businesses	AGRANT◷◆	13,514	—	—	—	Open the original filing on SEC.gov
Feb 18	Doherty Catherine T.	EVP, Regional Businesses	FTAX◷	728	$206.99	$150.7K	-1.0%	Open the original filing on SEC.gov
Feb 18	Doherty Catherine T.	EVP, Regional Businesses	FTAX◷	433	$210.01	$90.9K	-0.6%	Open the original filing on SEC.gov
Feb 18	Doherty Catherine T.	EVP, Regional Businesses	AGRANT◷	2,928	—	—	+4.3%	Open the original filing on SEC.gov
Feb 18	Deppe Michael J	SVP, Corp. Controller &…	AGRANT◆	1,688	—	—	—	Open the original filing on SEC.gov
Feb 18	Deppe Michael J	SVP, Corp. Controller &…	FTAX	99	$206.99	$20.5K	-0.3%	Open the original filing on SEC.gov
Feb 18	Deppe Michael J	SVP, Corp. Controller &…	FTAX	83	$210.01	$17.4K	-0.2%	Open the original filing on SEC.gov
Feb 18	Deppe Michael J	SVP, Corp. Controller &…	AGRANT	366	—	—	+1.1%	Open the original filing on SEC.gov

SSELL◷$2.4M

Davis J. E. · CEO and PresidentSep 1

10,000 sh @ $242.72 · -7.5% own

MEXER◷◆$2.5M

Prevoznik Michael E · SVP & General…Aug 28

22,677 sh @ $112.17

GGIFT◷—

Prevoznik Michael E · SVP & General…Aug 28

1,000 sh · -2.7% own

SSELL◷$105.1K

Prevoznik Michael E · SVP & General…Aug 28

430 sh @ $244.51 · -1.1% own

SSELL◷$1.5M

Prevoznik Michael E · SVP & General…Aug 28

6,237 sh @ $243.63 · -14.1% own

SSELL◷$3.9M

Prevoznik Michael E · SVP & General…Aug 28

16,010 sh @ $242.88 · -26.6% own

MEXER◷$2.5M

Prevoznik Michael E · SVP & General…Aug 28

22,677 sh @ $112.17 · +60.4% own

SSELL◷$376.3K

Delaney Mark E · SVP & Chief…Jul 28

1,600 sh @ $235.18 · -13.4% own

AGRANT$21.1K

Samad Sam · Executive Vice…Jul 22

102 sh @ $206.81 · +0.3% own

LSMALL$9.5K

Plewman Patrick · SVP for Diagnostic…Jul 22

46 sh @ $206.81 · +0.3% own

LSMALL$4.3K

Main Timothy L · DirectorJul 22

21 sh @ $206.81 · +<0.1% own

LSMALL$1.2K

Lassiter Wright III · DirectorJul 22

6 sh @ $206.81 · +<0.1% own

LSMALL$7.7K

Kuppusamy Karthik · SVP, Clinical…Jul 22

37 sh @ $206.81 · +0.3% own

AGRANT$14.9K

Gregg Vicky B · DirectorJul 22

72 sh @ $206.81 · +0.4% own

LSMALL$7K

Delaney Mark E · SVP & Chief…Jul 22

34 sh @ $206.81 · +0.3% own

LSMALL$2.3K

Carter Robert B · DirectorJul 22

11 sh @ $206.80 · +0.3% own

AGRANT◆—

Wentworth Timothy C · DirectorJul 1

144 sh

MEXER◷◆$588K

Kuppusamy Karthik · SVP, Clinical…Jun 4

4,827 sh @ $121.81

MEXER◷◆$424K

Kuppusamy Karthik · SVP, Clinical…Jun 4

3,320 sh @ $127.73

SSELL◷$1.6M

Kuppusamy Karthik · SVP, Clinical…Jun 4

8,147 sh @ $200.00 · -37.6% own

MEXER◷$588K

Kuppusamy Karthik · SVP, Clinical…Jun 4

4,827 sh @ $121.81 · +28.7% own

MEXER◷$424K

Kuppusamy Karthik · SVP, Clinical…Jun 4

3,320 sh @ $127.73 · +24.6% own

SSELL◷$1.9M

Davis J. E. · CEO and PresidentJun 1

10,000 sh @ $194.14 · -7.0% own

AGRANT—

Wentworth Timothy C · DirectorMay 20

1,142 sh · +528.7% own

AGRANT—

Ring Timothy M · DirectorMay 20

1,142 sh · +3.8% own

AGRANT—

Pfeiffer Gary M · DirectorMay 20

1,142 sh · +3.8% own

AGRANT—

Morrison Denise M · DirectorMay 20

1,142 sh · +10.6% own

AGRANT—

Main Timothy L · DirectorMay 20

1,142 sh · +4.3% own

AGRANT—

Lassiter Wright III · DirectorMay 20

1,142 sh · +12.4% own

AGRANT—

Gregg Vicky B · DirectorMay 20

1,142 sh · +6.7% own

AGRANT—

Doi Tracey · DirectorMay 20

1,142 sh · +17.3% own

AGRANT—

Diaz Luis · DirectorMay 20

1,142 sh · +28.2% own

AGRANT—

Carter Robert B · DirectorMay 20

1,142 sh · +42.1% own

AGRANT$21K

Samad Sam · Executive Vice…Apr 20

108 sh @ $194.70 · +0.3% own

LSMALL$9.5K

Plewman Patrick · SVP for Diagnostic…Apr 20

49 sh @ $194.70 · +0.3% own

LSMALL$1.2K

Lassiter Wright III · DirectorApr 20

6 sh @ $194.70 · +<0.1% own

LSMALL$7.6K

Kuppusamy Karthik · SVP, Clinical…Apr 20

39 sh @ $194.70 · +0.3% own

AGRANT$13.2K

Gregg Vicky B · DirectorApr 20

68 sh @ $194.70 · +0.4% own

LSMALL$7.2K

Delaney Mark E · SVP & Chief…Apr 20

37 sh @ $194.70 · +0.3% own

LSMALL$1.4K

Carter Robert B · DirectorApr 20

7 sh @ $194.70 · +0.3% own

AGRANT◆—

Wentworth Timothy C · DirectorApr 1

198 sh

AGRANT—

Wentworth Timothy C · DirectorMar 9

215 sh

SSELL◷$588.7K

Plewman Patrick · SVP for Diagnostic…Mar 5

2,855 sh @ $206.21 · -15.8% own

SSELL◷$799.7K

Prevoznik Michael E · SVP & General…Mar 5

3,878 sh @ $206.21 · -9.4% own

SSELL◷$1.1M

Doherty Catherine T. · EVP, Regional…Mar 5

5,558 sh @ $206.21 · -7.6% own

FTAX$1.6M

Samad Sam · Executive Vice…Mar 4

7,720 sh @ $204.86 · -18.8% own

AGRANT$2.9M

Samad Sam · Executive Vice…Mar 4

13,947 sh @ $204.86 · +51.6% own

FTAX◷$579.1K

Plewman Patrick · SVP for Diagnostic…Mar 4

2,827 sh @ $204.86 · -13.5% own

AGRANT◷$1.2M

Plewman Patrick · SVP for Diagnostic…Mar 4

5,682 sh @ $204.86 · +37.4% own

FTAX◷$687.1K

Prevoznik Michael E · SVP & General…Mar 4

3,354 sh @ $204.86 · -7.5% own

AGRANT◷$1.5M

Prevoznik Michael E · SVP & General…Mar 4

7,232 sh @ $204.86 · +19.3% own

SSELL$538.4K

Kuppusamy Karthik · SVP, Clinical…Mar 4

2,628 sh @ $204.86 · -16.4% own

AGRANT$1.3M

Kuppusamy Karthik · SVP, Clinical…Mar 4

6,200 sh @ $204.86 · +62.8% own

FTAX◷$1.2M

Doherty Catherine T. · EVP, Regional…Mar 4

5,806 sh @ $204.86 · -7.4% own

AGRANT◷$2.3M

Doherty Catherine T. · EVP, Regional…Mar 4

11,364 sh @ $204.86 · +16.9% own

FTAX$153.6K

Deppe Michael J · SVP, Corp. Control…Mar 4

750 sh @ $204.86 · -2.1% own

AGRANT$301.8K

Deppe Michael J · SVP, Corp. Control…Mar 4

1,473 sh @ $204.86 · +4.3% own

FTAX$5.4M

Davis J. E. · CEO and PresidentMar 4

26,414 sh @ $204.86 · -15.6% own

AGRANT$10.6M

Davis J. E. · CEO and PresidentMar 4

51,652 sh @ $204.86 · +44.1% own

FTAX$476.5K

Delaney Mark E · SVP & Chief…Mar 4

2,326 sh @ $204.86 · -16.4% own

AGRANT$1.2M

Delaney Mark E · SVP & Chief…Mar 4

5,682 sh @ $204.86 · +66.8% own

SSELL◷$85.2K

Plewman Patrick · SVP for Diagnostic…Mar 3

410 sh @ $207.73 · -2.6% own

SSELL◷$109.3K

Prevoznik Michael E · SVP & General…Mar 3

526 sh @ $207.73 · -1.4% own

SSELL◷$131.3K

Doherty Catherine T. · EVP, Regional…Mar 3

632 sh @ $207.73 · -0.9% own

FTAX$178K

Samad Sam · Executive Vice…Mar 2

869 sh @ $204.86 · -3.1% own

FTAX◷$47.1K

Plewman Patrick · SVP for Diagnostic…Mar 2

230 sh @ $204.86 · -1.5% own

FTAX◷$59K

Prevoznik Michael E · SVP & General…Mar 2

288 sh @ $204.86 · -0.8% own

FTAX$42K

Kuppusamy Karthik · SVP, Clinical…Mar 2

205 sh @ $204.86 · -2.0% own

FTAX◷$132.7K

Doherty Catherine T. · EVP, Regional…Mar 2

648 sh @ $204.86 · -0.9% own

FTAX$18K

Deppe Michael J · SVP, Corp. Control…Mar 2

88 sh @ $204.86 · -0.3% own

SSELL◷$2.1M

Davis J. E. · CEO and PresidentMar 2

10,000 sh @ $212.52 · -7.9% own

FTAX◷$608K

Davis J. E. · CEO and PresidentMar 2

2,968 sh @ $204.86 · -2.3% own

FTAX$38.5K

Delaney Mark E · SVP & Chief…Mar 2

188 sh @ $204.86 · -2.2% own

SSELL◷$196.2K

Plewman Patrick · SVP for Diagnostic…Feb 19

958 sh @ $204.83 · -5.7% own

SSELL◷$227.6K

Prevoznik Michael E · SVP & General…Feb 19

1,111 sh @ $204.83 · -2.8% own

SSELL◷$293.5K

Doherty Catherine T. · EVP, Regional…Feb 19

1,433 sh @ $204.83 · -2.1% own

AGRANT◆—

Samad Sam · Executive Vice…Feb 18

18,303 sh

FTAX$209.1K

Samad Sam · Executive Vice…Feb 18

1,010 sh @ $206.99 · -3.5% own

FTAX$179.6K

Samad Sam · Executive Vice…Feb 18

855 sh @ $210.01 · -2.9% own

AGRANT—

Samad Sam · Executive Vice…Feb 18

3,965 sh · +15.4% own

AGRANT◷◆—

Plewman Patrick · SVP for Diagnostic…Feb 18

9,009 sh

FTAX◷$60.6K

Plewman Patrick · SVP for Diagnostic…Feb 18

293 sh @ $206.99 · -1.7% own

FTAX◷$51.2K

Plewman Patrick · SVP for Diagnostic…Feb 18

244 sh @ $210.01 · -1.4% own

AGRANT◷—

Plewman Patrick · SVP for Diagnostic…Feb 18

1,952 sh · +12.7% own

AGRANT◷◆—

Prevoznik Michael E · SVP & General…Feb 18

9,289 sh

FTAX◷$71.8K

Prevoznik Michael E · SVP & General…Feb 18

347 sh @ $206.99 · -0.9% own

FTAX◷$63.2K

Prevoznik Michael E · SVP & General…Feb 18

301 sh @ $210.01 · -0.8% own

AGRANT◷—

Prevoznik Michael E · SVP & General…Feb 18

2,013 sh · +5.3% own

AGRANT◆—

Kuppusamy Karthik · SVP, Clinical…Feb 18

9,853 sh

AGRANT—

Kuppusamy Karthik · SVP, Clinical…Feb 18

2,135 sh · +27.0% own

FTAX$53.6K

Kuppusamy Karthik · SVP, Clinical…Feb 18

259 sh @ $206.99 · -3.2% own

FTAX$52.9K

Kuppusamy Karthik · SVP, Clinical…Feb 18

252 sh @ $210.01 · -3.0% own

AGRANT◷◆—

Doherty Catherine T. · EVP, Regional…Feb 18

13,514 sh

FTAX◷$150.7K

Doherty Catherine T. · EVP, Regional…Feb 18

728 sh @ $206.99 · -1.0% own

FTAX◷$90.9K

Doherty Catherine T. · EVP, Regional…Feb 18

433 sh @ $210.01 · -0.6% own

AGRANT◷—

Doherty Catherine T. · EVP, Regional…Feb 18

2,928 sh · +4.3% own

AGRANT◆—

Deppe Michael J · SVP, Corp. Control…Feb 18

1,688 sh

FTAX$20.5K

Deppe Michael J · SVP, Corp. Control…Feb 18

99 sh @ $206.99 · -0.3% own

FTAX$17.4K

Deppe Michael J · SVP, Corp. Control…Feb 18

83 sh @ $210.01 · -0.2% own

AGRANT—

Deppe Michael J · SVP, Corp. Control…Feb 18

366 sh · +1.1% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

26 of 108 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 13 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Jan 28	Feb 19	Delaney Mark ESVP & Chief Commercial Officer	13days	$47.6K	Filing ↗
Jan 28	Feb 19	Lassiter Wright IIIDirector	13days	$1.3K	Filing ↗
Jan 28	Feb 19	Carter Robert BDirector	13days	$1.1K	Filing ↗
Jan 28	Feb 19	Gregg Vicky BDirector	13days	$12.3K	Filing ↗
Jan 28	Feb 19	Kuppusamy KarthikSVP, Clinical Solutions	13days	$53.6K	Filing ↗

Delaney Mark ESVP & Chief Commercial Officer

13days